Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
BioVie Logo
BioVie Growth Score
61
CB Rank
87056
Heat Score
51
BioVie specializes in the development of innovative solutions for the treatment of neurodegenerative and liver diseases.
Founded
obfuscation
PublicPost-IPO Equity Beverly, Massachusetts, United States11-50 bioviepharma.com
Biotechnology
Clinical Trials
Health Care
Innovation Management
Neuroscience
Therapeutics
Wellness
Overview

BioVie
Total Funding
obfuscation
Growth Score
61
Heat Score
51

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score61
-14 pts
in past quarter
Heat Score 51
-4 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About BioVie

CB Rank
87056
BioVie specializes in the development of innovative solutions for the treatment of neurodegenerative and liver diseases.
Founded
obfuscation
PublicPost-IPO Equity Beverly, Massachusetts, United States11-50 bioviepharma.com
Biotechnology
Clinical Trials
Health Care
Innovation Management
Neuroscience
Therapeutics
Wellness

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation

Key People

Details

Legal Name BioVie Inc.
Also Known As NanoAntibiotics
Operating Status Active
Stock Symbol  NASDAQ:BIVI
Company Type For Profit
Founders  Cuong Do
About the Company
BioVie is a purpose-driven company. BioVie develops new solutions to help people live healthier and better lives via innovation, cooperation, and people-centered science.
Phone Number +1 312-283-5793
Contact Email info@biovieinc.com
Predictions & Insights

Growth Insight

See this Growth Insight
BioVie is
Lorem
 to be growing
Top Contributing Factors
Operations Expansion

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Key Employee Changes

Products & Services

bezisterim (NE3107)
A molecule under clinical investigation for treating neurodegenerative diseases by modulating inflammation and enhancing brain energy transfer.
BIV201
A continuous infusion formulation of terlipressin for outpatient treatment of refractory ascites due to liver cirrhosis.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 9
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - BioVie Logo
Post-IPO Equity - BioVie
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - BioVie Logo
Post-IPO Equity - BioVie
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - BioVie Logo
Post-IPO Equity - BioVie
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - BioVie Logo
Post-IPO Equity - BioVie
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - BioVie Logo
Post-IPO Equity - BioVie
—
obfuscation
— Post-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 9
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - BioVie Logo
Post-IPO Equity - BioVie
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - BioVie Logo
Post-IPO Equity - BioVie
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - BioVie Logo
Post-IPO Equity - BioVie
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - BioVie Logo
Post-IPO Equity - BioVie
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - BioVie Logo
Post-IPO Equity - BioVie
—
obfuscation
— Post-IPO Equity

Investors

Investments

Number of Acquisitions 1

Investment Breakdown

Number of Acquisitions 1
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 9 Board Members and Advisors 3 Contacts 14

Employee Profiles

Board Members and Advisors

News

News and Press

News•Jun 5, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 5, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 29, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 26, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

1,234
-47.35%
 in past month

IT Spend

$228.3KThis year, BioVie is projected to spend $228.3K on IT, according to Aberdeen.

Active Website Tech Count

3BioVie is actively using 3 technologies for its website, according to BuiltWith. These include CommonCrawl Top 50m and  Bizo.

Total IP

23The intellectual property of BioVie includes 23 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is BioVie's headquarters? BioVie is located in Beverly, Massachusetts, United States.Who invested in BioVie? BioVie is funded by Avenue Capital Group.When was the last funding round for BioVie? BioVie closed its last funding round on
obfuscation
from a Post-IPO Equity round.Who are BioVie's competitors? Alternatives and possible competitors to BioVie may include BioAge Labs, Axonis Therapeutics, and  Tenvie Therapeutics.How much funding has BioVie raised to date? BioVie has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(411cf44 1)
|